[go: up one dir, main page]

AU467361B2 - Q-aryl-4-substituted piperidinoalkanol derivatives - Google Patents

Q-aryl-4-substituted piperidinoalkanol derivatives

Info

Publication number
AU467361B2
AU467361B2 AU49893/72A AU4989372A AU467361B2 AU 467361 B2 AU467361 B2 AU 467361B2 AU 49893/72 A AU49893/72 A AU 49893/72A AU 4989372 A AU4989372 A AU 4989372A AU 467361 B2 AU467361 B2 AU 467361B2
Authority
AU
Australia
Prior art keywords
aryl
piperidinoalkanol derivatives
substituted
substituted piperidinoalkanol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU49893/72A
Other versions
AU4989372A (en
Inventor
and CLYDE RICHARD KINSOLVING ALBERT ANTHONY CARR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22829539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU467361(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of AU4989372A publication Critical patent/AU4989372A/en
Application granted granted Critical
Publication of AU467361B2 publication Critical patent/AU467361B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU49893/72A 1972-01-28 1972-12-11 Q-aryl-4-substituted piperidinoalkanol derivatives Ceased AU467361B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22182172A 1972-01-28 1972-01-28
USUS221,821 1972-01-28

Publications (2)

Publication Number Publication Date
AU4989372A AU4989372A (en) 1974-06-13
AU467361B2 true AU467361B2 (en) 1975-11-27

Family

ID=22829539

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49893/72A Ceased AU467361B2 (en) 1972-01-28 1972-12-11 Q-aryl-4-substituted piperidinoalkanol derivatives

Country Status (26)

Country Link
JP (1) JPS5115035B2 (en)
AR (1) AR195314A1 (en)
AT (2) AT321917B (en)
AU (1) AU467361B2 (en)
BE (1) BE794597A (en)
CA (1) CA978946A (en)
CH (2) CH593259A5 (en)
CS (1) CS177834B2 (en)
DD (1) DD103239A5 (en)
DE (1) DE2303306C3 (en)
DK (1) DK136713B (en)
ES (1) ES410731A1 (en)
FR (1) FR2181690B1 (en)
GB (1) GB1413138A (en)
HU (1) HU166477B (en)
IE (1) IE36983B1 (en)
IL (1) IL41060A (en)
LU (1) LU66916A1 (en)
NL (1) NL175410C (en)
NO (1) NO140057C (en)
PH (1) PH10264A (en)
PL (1) PL89095B1 (en)
SE (1) SE382058B (en)
SU (1) SU464997A3 (en)
YU (1) YU36013B (en)
ZA (1) ZA728544B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941795A (en) 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
IT1200123B (en) * 1985-09-27 1989-01-05 Ind Chimica Srl PROCESS FOR ALPHA PREPARATION
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
JPS63101760U (en) * 1986-12-19 1988-07-02
IT1205685B (en) * 1987-05-26 1989-03-31 Erregierre Spa PROCESS FOR THE PREPARATION OF ALPHA- (ALCHYLPHENYL) -4- (HYDROXY DIPHENYLMETHYL) -1-PIPERIDINE BUTANOL
IL93499A0 (en) * 1989-02-28 1990-11-29 Merrell Dow Pharma Preparation of the low melting polymorphic form of terfenadine
ZA903145B (en) * 1989-05-01 1991-02-27 Merrell Dow Pharma Process for the preparation of the high melting polymorphic form of terfenadine
DE3917241A1 (en) * 1989-05-26 1990-11-29 Schaper & Bruemmer Gmbh 4- (HYDROXYDIPHENYLMETHYL) -1-PIPERIDYL-PHENYLALKANE DERIVATIVES
US5466691A (en) * 1991-08-09 1995-11-14 Yoshitomi Pharmaceutical Industries, Ltd. Thiophene compound
WO1996035667A1 (en) * 1995-05-08 1996-11-14 Hoescht Marion Roussel, Inc. Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
PT864653E (en) * 1997-03-11 2004-08-31 Aventis Pharma Inc PROCESS FOR PREPARATION OF 4- (4- (4- (HYDROXIDIFENYL) -1-PIPERIDINYL) -1-HYDROXIBUTIL) -ALFA, ALPHA-DIMETHYLPHENYL ACETATE AND PHOSPHORYLED DERIVATIVES
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
WO2006043691A1 (en) * 2004-10-18 2006-04-27 Reverse Proteomics Research Institute Co., Ltd. Target protein and target gene in drug designing and screening method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081303A (en) * 1961-10-13 1963-03-12 Searle & Co 1-aminoalkyl-alpha, alpha-diphenylpiperidine-methanols
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives

Also Published As

Publication number Publication date
DE2303306C3 (en) 1979-05-31
IE36983L (en) 1973-07-28
ZA728544B (en) 1974-02-27
PL89095B1 (en) 1976-10-30
IL41060A0 (en) 1973-02-28
PH10264A (en) 1976-10-20
CS177834B2 (en) 1977-08-31
CH587820A5 (en) 1977-05-13
IE36983B1 (en) 1977-04-13
NL175410B (en) 1984-06-01
LU66916A1 (en) 1973-07-27
GB1413138A (en) 1975-11-05
YU3473A (en) 1981-02-28
BE794597A (en) 1973-05-16
ES410731A1 (en) 1976-04-01
DK136713C (en) 1978-05-01
CA978946A (en) 1975-12-02
DD103239A5 (en) 1974-01-12
NL175410C (en) 1984-11-01
NO140057B (en) 1979-03-19
AT323742B (en) 1975-07-25
YU36013B (en) 1981-11-13
AU4989372A (en) 1974-06-13
IL41060A (en) 1975-06-25
DK136713B (en) 1977-11-14
FR2181690B1 (en) 1976-05-14
NL7300873A (en) 1973-07-31
CH593259A5 (en) 1977-11-30
DE2303306B2 (en) 1978-09-28
JPS5115035B2 (en) 1976-05-13
JPS4885578A (en) 1973-11-13
DE2303306A1 (en) 1973-08-02
SE382058B (en) 1976-01-12
SU464997A3 (en) 1975-03-25
NO140057C (en) 1979-07-04
AT321917B (en) 1975-04-25
AR195314A1 (en) 1973-09-28
HU166477B (en) 1975-03-28
FR2181690A1 (en) 1973-12-07

Similar Documents

Publication Publication Date Title
AU467361B2 (en) Q-aryl-4-substituted piperidinoalkanol derivatives
AU496759B2 (en) New pregnan-21-oic derivatives
CA1019738A (en) Isothiocyanopyridine derivatives
AU470719B2 (en) Oxazinoindole-and thiazinoinindole derivatives
AU467405B2 (en) Diphenylalkyllactamimide derivatives
CA1020946A (en) 1-phenoxy-3-phenoxyethylamino-2-propanol derivatives
AU470763B2 (en) Pyrano-and thiopyranoindole derivatives
CA1006514A (en) Beta-aminoketone derivatives
CA1018161A (en) Indan-1-carboxamide derivatives
CA978526A (en) Pyrano- and thiopyranoindole derivatives
CA981684A (en) Cyclopenteno-quinolone derivatives
AU5556173A (en) New nitrofuryl-amidine derivatives
CA912581A (en) Zearalane derivatives
CA899353A (en) 1-hydroxyproline derivatives
CA892056A (en) Sulphonamidopyrazolinone derivatives
CA896560A (en) 6-phenyl-dihydropyridazine-3-one derivatives
CA1012557A (en) 2-amino-1-phenyl-butane derivatives
CA898253A (en) Styryl-naphthalene derivatives
CA917653A (en) N-sulphonamide-succinimide derivatives
CA916153A (en) Dihydropyrimidopyridazine derivatives
CA910910A (en) Pyrimidinylpyrazole derivatives
CA891502A (en) Benhydrylquinuclidinol derivatives
CA899886A (en) Oxotremarine derivatives
CA901015A (en) Benzophenonimine derivatives
AU483221B2 (en) Benzo-di-pyran derivatives